Grifols S.A. Acciones Port. Clas/ ES0171996087 /
2024-06-11 6:56:29 PM | Chg. -0.1240 | Volume | Bid8:34:14 PM | Ask8:34:14 PM | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
9.0980EUR | -1.34% | 100 Turnover: 909.8000 |
9.0660Bid Size: 280 | 9.1640Ask Size: 280 | 7.46 bill.EUR | - | 100.20 |
GlobeNewswire
04-18
Grifols Celebrates 50 Years of Manufacturing Life-Changing Plasma-Derived Medicines for Patients at ...
GlobeNewswire
04-04
Grifols Procleix ArboPlex Assay® Receives CE Mark, the First and Only 4-in-1 NAT for Arbovirus Scree...
GlobeNewswire
2023-11-15
Grifols Completes Cohort 1 in Clinical Study of Alpha-1 15%, Evaluating First-in-Human Subcutaneous ...